Advertisements



We are Sorry, This Page doesn't Exist


Acceleron Pharma Rallies After Phase 3 MDS Data, But Goldman Sachs Still Isn"t Buying

Acceleron Pharma Inc (NASDAQ: XLRN), a clinical-stage biopharmaceutical focused on the treatment of serious and rare diseases, saw its stock soar after reporting encouraging Phase 3 data. Lates.....»»

Category: blogSource: benzingaJun 29th, 2018

Flex Pharma Down on Workforce Reduction, Ends Phase II Study

Flex Pharma (FLKS) announced that the company is ending the phase II studies for its pipeline candidate FLX-787 in two indications. The company also plans to lower its workforce by about 60%. F.....»»

Category: smallbizSource: nytJun 14th, 2018

Technical Take: Spectrum rallies on Anerson"s Phase 2 data of poziotinib

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 10th, 2018

This Binance Labs-Backed Crypto Startup Wants to Anonymize Everything

Built atop a near-forgotten anonymity system named mix networks, Nym Technologies is entering the proof-of-concept phase following a 10-week incubation program with Binance Labs......»»

Category: forexSource: coindeskDec 14th, 2018

Prairiefire secures first tenant for final phase

Merrill Cos. LLC has secured the first tenant for the final phase of its Prairiefire development in Overland Park.  Construction on the final phase of office and retail is slated to start in the spring. The first tenant signed up in the new addit.....»»

Category: topSource: bizjournalsDec 14th, 2018

This Binance-Backed Crypto Startup Wants to Anonymize Everything

Built atop a near-forgotten anonymity system named mix networks, Nym Technologies is entering the proof-of-concept phase following a 10-week incubation program with Binance Labs......»»

Category: forexSource: coindeskDec 14th, 2018

Torchlight Energy Resources completes drilling phase of A39 #1 well

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallDec 14th, 2018

Pfizer initiates Phase 3 program for 20-Valent pneumococcal conjugate vaccine

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallDec 14th, 2018

Idera Pharmaceuticals presents data from Phase 2 expansion of ILUMMINATE-204

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallDec 14th, 2018

Leap Therapeutics presents final data from the Phase I/II study of DKN-01

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallDec 14th, 2018

Aptevo Therapeutics doses first patient in Phase 1/1b trial of APVO436

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallDec 13th, 2018

Protagonist Therapeutics begins Phase 1 trial of inflammatory bowel disease drug

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallDec 13th, 2018

Rhythm Pharmaceuticals enrolls first patient in Phase 3 setmelanotide trial

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallDec 13th, 2018

Tesla, Inc. (NASDAQ:TSLA) set to move past its drama phase?

Tesla, Inc. (NASDAQ:TSLA) set to move past its drama phase? At times—like, say, this week—that seems hard to believe. After a news-filled appearance on 60 Minutes, for example, Elon Musk said portions of the interv.....»»

Category: topSource: livetradingnewsDec 13th, 2018

Summerfest Foundation merged into main organization; charity work will continue

The foundation, created in 2011, arose as part of Milwaukee World Festival's New Markets Tax Credit transaction that supported phase two of the south end reconstruction of Henry W. Maier Festival Park, which primarily included the BMO Harris Pavilion......»»

Category: topSource: bizjournalsDec 12th, 2018

All grown up: How expansion changed my role as CEO

As the company has grown past the startup phase, I now find myself being called on to perform the duties of an executive far more than those of an entrepreneur......»»

Category: topSource: moneycentralDec 12th, 2018

Generex receives IND approval from FDA for Phase II combination study

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallDec 12th, 2018

Janssen says Phase 3 data demonstrate superiority of Tremfya vs. Consentyx

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallDec 12th, 2018

Aridis Pharmaceuticals enrolls first subject in Phase 1/2a lung infection trial

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallDec 12th, 2018

Neurocrine says valbenazine did not meet primary endpoint in Phase IIb study

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallDec 12th, 2018